News

Regeneron Announces Free Gene Therapy Otarmeni for Rare Hearing Loss in U.S. Government Agreement

2 min

Pharma Partnering US: Biotech Dealmaking Heats Up

biotech · 8 min

COG 2024: Daily Highlights and Key Takeaways

general · 3 min

ASCO 2026: Key Oncology Data Readouts to Watch

oncology · 5 min

ASCO 2026: Top Oncology Trials to Watch

oncology · 5 min

Pharma Partnering US: Biotech Deals & Investment Trends Day 1

biotech · 8 min

AOP Health US Treats First Patient with Rapiblyk (Landiolol) in United States at Valley Hospital

2 min

Emergent BioSolutions Partners with Substipharm for $34.5M Japanese Encephalitis Vaccine Manufacturing Deal

2 min

Zealand Pharma's Survodutide Achieves 16.6% Weight Loss in Phase 3 Obesity Trial, Outperforming Current GLP-1 Therapies

Obesity and Weight Management · 3 min

Ashvattha Therapeutics Presents Migaldendranib Data for Diabetic Macular Edema and AMD Treatment

EMA · 2 min

Aclaris Therapeutics ATI-052 Shows Promising 45-Day Half-Life in Phase 1a Trial Results

2 min

Trevi Therapeutics Schedules Q1 2026 Earnings Call for Haduvio Chronic Cough Treatment Updates

2 min